Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology – Gynecologic Oncology Group Study 240 (NCT 00803062)

To isolate circulating tumor cells (CTCs) from women with advanced cervical cancer and estimate the impact of CTCs and treatment on overall survival (OS) and progression-free survival (PFS). 7.5 mL of whole blood was drawn pre-cycle 1 and 36 days post-cycle 1 from patients enrolled on Gynecologic On...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cancer Ther
Autors principals: Tewari, Krishnansu S., Sill, Michael W, Monk, Bradley J., Penson, Richard T., Moore, David H., Lankes, Heather A, Ramondetta, Lois M., Landrum, Lisa M., Randall, Leslie M., Oaknin, Ana, Leitao, Mario M., Eisenhauer, Eric L., DiSilvestro, Paul, Van Le, Linda, Pearl, Michael L., Burke, James J., Salani, Ritu, Richardson, Debra L., Michael, Helen E., Kindelberger, David W., Birrer, Michael J
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7907274/
https://ncbi.nlm.nih.gov/pubmed/32847980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-20-0276
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars